Please login to the form below

Not currently logged in
Email:
Password:

PR and Med Ed news in brief

Our weekly round up of healthcare PR stories

Women at great risk

The British Lung Foundation has warned that rates of chronic obstructive pulmonary disease are soaring. COPD could soon be the fourth biggest killer of women yet just 1 per cent of 1,200 women surveyed said that the disease was their main health worry.

Women fear breast cancer more than other diseases and 27 per cent thought it, not heart disease, killed most women in the UK. Smokers have slightly more awareness of COPD: their habit means that they are at 13-times greater risk of developing the condition.

The charity has been working on raising awareness of COPD and last month launched a practical guide for GPs, providing on managing COPD.

New campaign for von Willenbrand's disease

The Haemophilia Society is getting set to launch a campaign aimed at boosting awareness of little known condition, von Willebrand's disease. The initiative `Women Bleed Too' will focus on how bleeding disorders, although traditionally associated with men, also affect many women. The campaign, which is being promoted by Red Door Communications, is one of the most heavily funded specific awareness campaigns to be backed by the society in recent years. It will be launched in January 2006.

Von Willebrand's disease is mostly hereditary and inhibits normal clotting processes leading to prolonged bleeding. It affects around one in 100 women in the UK and is often discovered after surgery or major accident. The campaign will target consumer media and women of all ages, and will highlight treatments for the condition.

2nd September 2008

Share

COVID-19 Updates and Daily News

] [PR and Med Ed news in brief, Our weekly round up of healthcare PR stories , News Article, , ,] -->

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics